source
- FDA issues complete response letter rejecting Summit Therapeutics' lung cancer drugThe U.S. Food and Drug Administration released a complete response letter that rejects Summit Therapeutics' lung cancer candidate, providing the agency’s detailed reasons for the decision. The age…
- Epic Systems pledges broader AI access to its EHR data and defends its competitive practices at HLTH conferenceEpic Systems executives used a panel at the HLTH conference to respond to a STAT investigation that accused the company of limiting data access for rival developers. The company said it will make…